使用芬特明/托皮拉酸的耐火性尿酸石病溶解:一个案例报告.
Logan Buchanan1, Benjamin Canales2, Akira Yamamoto2
1University of Tennessee Health Science Center, United States.
芬特明/托皮拉 (Qsymia) 在肥胖患者中溶解了反复性尿酸结石. 这种减肥药物为尿酸石块溶解提供了一种新的非性方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿酸结石难以溶解,通常需要口服化疗法,如酸.
- 肥胖是尿酸石病的重要危险因素.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
